Brief: Esperion Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
25/09/2024 23:23
Esperion Therapeutics Inc ESPR.O :
* ESPERION ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING
RULE
5635(C)(4)
Source text for Eikon: ID:nGNX25Ldb0
Further company coverage: ESPR.O
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi